Literature DB >> 24005530

Mind the mortality gap: the importance of metabolic function in mental illnesses.

Oliver D Howes1, Katherine Beck.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24005530     DOI： 10.1007/s00213-013-3259-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  25 in total

Review 1.  Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia.

Authors:  Hu Yan; Jin-Dong Chen; Xiao-Yan Zheng
Journal:  Psychopharmacology (Berl)       Date:  2013-07-06       Impact factor: 4.530

Review 2.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

Authors:  Salvatore Mottillo; Kristian B Filion; Jacques Genest; Lawrence Joseph; Louise Pilote; Paul Poirier; Stéphane Rinfret; Ernesto L Schiffrin; Mark J Eisenberg
Journal:  J Am Coll Cardiol       Date:  2010-09-28       Impact factor: 24.094

3.  Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters.

Authors:  Kieran J Davey; Siobhain M O'Mahony; Harriet Schellekens; Orla O'Sullivan; John Bienenstock; Paul D Cotter; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2012-01-11       Impact factor: 4.530

4.  A prospective open-label trial of paliperidone monotherapy for the treatment of bipolar spectrum disorders in children and adolescents.

Authors:  Gagan Joshi; Carter Petty; Janet Wozniak; Stephen V Faraone; Andrea E Spencer; K Yvonne Woodworth; Rachel Shelley-Abrahamson; Hannah McKillop; Stephannie L Furtak; Joseph Biederman
Journal:  Psychopharmacology (Berl)       Date:  2013-02-09       Impact factor: 4.530

5.  A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and β-cell function in schizophrenic patients.

Authors:  Shaohua Hu; Mingrong Yao; Bradley S Peterson; Dongrong Xu; Jianbo Hu; Jianliang Tang; Bing Fan; Zhengluan Liao; Tianyi Yuan; Yaling Li; Weiqing Yue; Ning Wei; Weihua Zhou; Manli Huang; Yi Xu
Journal:  Psychopharmacology (Berl)       Date:  2013-04-05       Impact factor: 4.530

6.  Time-dependent effects of haloperidol on glutamine and GABA homeostasis and astrocyte activity in the rat brain.

Authors:  Glenn T Konopaske; Nicolas R Bolo; Alo C Basu; Perry F Renshaw; Joseph T Coyle
Journal:  Psychopharmacology (Berl)       Date:  2013-05-10       Impact factor: 4.530

7.  National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.

Authors:  E Mannucci; M Monami; B Cresci; L Pala; G Bardini; M G Petracca; I Dicembrini; A Pasqua; E Buiatti; C M Rotella
Journal:  Diabetes Obes Metab       Date:  2007-04-05       Impact factor: 6.577

8.  The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole.

Authors:  Euitae Kim; Oliver D Howes; Federico E Turkheimer; Bo-Hyung Kim; Jae Min Jeong; Ji Who Kim; Jae Sung Lee; In-Jin Jang; Sang-Goo Shin; Shitij Kapur; Jun Soo Kwon
Journal:  Psychopharmacology (Berl)       Date:  2012-12-28       Impact factor: 4.530

9.  Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study.

Authors:  Michael Poyurovsky; Camil Fuchs; Artashez Pashinian; Aya Levi; Sarit Faragian; Rachel Maayan; Irit Gil-Ad
Journal:  Psychopharmacology (Berl)       Date:  2007-02-20       Impact factor: 4.415

10.  Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat.

Authors:  Goran Jassim; Silje Skrede; María Jesús Vázquez; Hege Wergedal; Audun O Vik-Mo; Niclas Lunder; Carlos Diéguez; Antonio Vidal-Puig; Rolf K Berge; Miguel López; Vidar M Steen; Johan Fernø
Journal:  Psychopharmacology (Berl)       Date:  2011-07-12       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.